Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Xenon Pharmaceuticals Inc XENE

Xenon Pharmaceuticals Inc. is a Canada-based neuroscience-focused biopharmaceutical company committed to discovering, developing, and commercializing therapeutics to improve the lives of people living with neurological and psychiatric disorders. The Company is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. Azetukalner, the... see more

Recent & Breaking News (NDAQ:XENE)

Xenon Pharmaceuticals Appoints Dr. Richard H. Scheller to Its Board of Directors

GlobeNewswire March 16, 2015

Xenon Pharmaceuticals Reports 2014 Financial Results and Provides Corporate Update

GlobeNewswire March 12, 2015

Xenon Pharmaceuticals to Host Conference Call and Webcast to Discuss 2014 Financial Results and Provide Corporate Update

GlobeNewswire March 9, 2015

Xenon Pharmaceuticals' Partner Teva to Initiate Phase 2b Clinical Trial of TV-45070 in Post-Herpetic Neuralgia

GlobeNewswire February 19, 2015

Xenon Pharmaceuticals Outlines Key Anticipated Milestones for 2015

GlobeNewswire January 8, 2015

Xenon Pharmaceuticals Reports Third Quarter 2014 Financial Results

GlobeNewswire December 15, 2014

Xenon Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

GlobeNewswire November 10, 2014

Xenon Pharmaceuticals Announces Pricing of Initial Public Offering

GlobeNewswire November 4, 2014